Kramer I, Konig L, Luft T, Hegenbart U, et al. Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma. Bone Marrow Transplant 2025 Feb 13. doi: 10.1038/s41409-025-02522.
PMID: 39948382